...以有皮肤瘙痒,脂肪泻,血清碱性磷酸酶(ALP)、谷氨酰转肽酶(GGT)升高、抗线粒体(AMA)抗体阳性是本病的重要特征。熊去氧胆酸(UDCA)是唯一经随机双盲临床试验证明对本病有效的药物,需要终生服用。此药几无毒副作用,仅部分病人在开始服用时有轻度腹泻。
基于2734个网页-相关网页
ursodeoxycholic acid UDCA 熊去氧胆酸 ; 熊脱氧胆酸
There is currently no consensus on how to treat patients with a suboptimal biochemical response to UDCA.
目前,对udca应答欠佳患者的治疗方法尚不确定。
Ursodeoxycholic acid (UDCA) is the only safe and effective drug for the treatment of PBC proven by randomized controlled clinical trials.
熊去氧胆酸(UDCA)是惟一经随机对照临床试验证实的 治疗PBC安全有效的药物。
ConclusionsAdministration of UDCA following cholangioenterostomy is safe, and it can significantly reduce the occurrence rate of retrograde biliary tract infection.
结论:胆肠吻合术后应用udca安全,可显著降低术后胆道逆行感染的发生率。
应用推荐